An opportunistic TO attempt is no doubt on the cards considering the SP damage carried out. Unfortunately for any potential suitor, they have no chance. Most SH’s know what this is worth and a successful friendly bid would need to be multiples of the current SP. A hostile TO would require 90% acceptance and that is unlikely considering the cash rolling in. This isn’t a distressed company situation.
- Forums
- ASX - By Stock
- PLS
- Good News & Bad News
Good News & Bad News, page-25712
-
- There are more pages in this discussion • 18,680 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.02 |
Change
-0.040(1.31%) |
Mkt cap ! $9.090B |
Open | High | Low | Value | Volume |
$3.08 | $3.11 | $3.02 | $55.82M | 18.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 424619 | $3.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.03 | 17344 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 329137 | 3.020 |
23 | 502241 | 3.010 |
92 | 359053 | 3.000 |
16 | 98735 | 2.990 |
19 | 101042 | 2.980 |
Price($) | Vol. | No. |
---|---|---|
3.040 | 32598 | 6 |
3.050 | 109743 | 7 |
3.060 | 104622 | 7 |
3.070 | 137237 | 8 |
3.080 | 1849 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online